The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Tricyclic drugs for depression in children and adolescents
Open accessAbstract
BACKGROUND: There is a need to identify effective and safe treatments for depression in children and adolescents. While tricyclic drugs are effective in treating depression in adults, individual studies involving children and adolescents have been equivocal. Prescribing of tricyclic drugs for depression in children and adolescents is now uncommon, but an accurate estimate of their efficacy is helpful as a comparator for other drug treatments for depression in this age group. This is an update of a Cochrane review first published in 2000 and updated in 2002, 2006 and 2010. OBJECTIVES: To assess the effects of tricyclic drugs compared with placebo for depression in children and adolescents and to determine whether there are differential responses to tricyclic drugs between child and adolescent patient populations. SEARCH METHODS: We conducted a search of the Cochrane Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR) (to 12 April 2013), which includes relevant randomised controlled trials from the following bibliographic databases: the Cochrane Central Register of Controlled Trials (CENTRAL) (all years), EMBASE (1974-), MEDLINE (1950-) and PsycINFO (1967-). The bibliographies of previously published reviews and papers describing original research were cross-checked. We contacted authors of relevant abstracts in conference proceedings of the American Academy of Child and Adolescent Psychiatry, and we handsearched the Journal of the American Academy of Child and Adolescent Psychiatry (1978 to 1999). SELECTION CRITERIA: Randomised controlled trials comparing the efficacy of orally administered tricyclic drugs with placebo in depressed people aged 6 to 18 years. DATA COLLECTION AND ANALYSIS: One of two review authors selected the trials, assessed their quality, and extracted trial and outcome data. A second review author assessed quality and checked accuracy of extracted data. Most studies reported multiple outcome measures including depression scales and clinical global impression scales. For each study, we took the best available depression measure as the index measure of depression outcome. We established predetermined criteria to assist in the ranking of measures. Where study authors reported categorical outcomes, we calculated individual and pooled risk ratios for non-improvement in treated compared with control subjects. For continuous outcomes, we calculated pooled effect sizes as the number of standard deviations by which the change in depression scores for the treatment group exceeded those for the control group. MAIN RESULTS: Fourteen trials (590 participants) were included. No overall difference was found for the primary outcome of response to treatment compared with placebo (risk ratio (RR) 1.07, 95% confidence interval (CI) 0.91 to 1.26; 9 trials, N = 454). There was a small reduction in depression symptoms (standardised mean difference (SMD) -0.32, 95% CI -0.59 to -0.04; 13 trials, N = 533), but the evidence was of low quality. Subgroup analyses suggested a small reduction in depression symptoms among adolescents (SMD -0.45, 95% CI -0.83 to -0.007), and negligible change among children (SMD 0.15, 95% CI -0.34 to 0.64). Treatment with a tricyclic antidepressant caused more vertigo (RR 2.76, 95% CI 1.73 to 4.43; 5 trials, N = 324), orthostatic hypotension (RR 4.86, 95% CI 1.69 to 13.97; 5 trials, N = 324), tremor (RR 5.43, 95% CI 1.64 to 17.98; 4 trials, N = 308) and dry mouth (RR 3.35, 95% CI 1.98 to 5.64; 5 trials, N = 324) than did placebo, but no differences were found for other possible adverse effects. Wide CIs and the probability of selective reporting mean that there was very low-quality evidence for adverse events.There was heterogeneity across the studies in the age of participants, treatment setting, tricyclic drug administered and outcome measures. Statistical heterogeneity was identified for reduction in depressive symptoms, but not for rates of remission or response. As such, the findings from analyses of pooled data should be interpreted with caution.We judged none of these trials to be at low risk of bias, with limited information about many aspects of risk of bias, high dropout rates, and issues regarding measurement instruments and the clinical usefulness of outcomes, which were often variously defined across trials. AUTHORS' CONCLUSIONS: Data suggest tricyclic drugs are not useful in treating depression in children. There is marginal evidence to support the use of tricyclic drugs in the treatment of depression in adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Childhood and adolescent depression: a review of the past 10 years, Part I
BIRMAHER, B., RYAN, N. D., WILLIAMSON, D. E., BRENT, D. A., KAUFMAN, J., DAHL, R. E., PEREL, J., & NELSON, B. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00011 · Cited by 2,076
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 985
KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641
Costello, E. J., Foley, D. L., & Angold, A. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000184929.41423.c0 · Cited by 441
Mechanism of action of antidepressant medications.
Feighner, J. P. (1999) · PubMed · Cited by 323
Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis
Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995) · BMJ · doi:10.1136/bmj.310.6984.897 · Cited by 308
Self-citationNewer generation antidepressants for depressive disorders in children and adolescents
Hetrick, S. E., McKenzie, J. E., Cox, G. R., Simmons, M. B., & Merry, S. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004851.pub3 · Cited by 291
Imipramine in Prepubertal Major Depressive Disorders
Puig-Antich, J. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800130093012 · Cited by 279
Barbey, J. T., & Roose, S. P. (1998) · PubMed · Cited by 247
Imipramine Plus Cognitive-Behavioral Therapy in the Treatment of School Refusal
BERNSTEIN, G. A., BORCHARDT, C. M., PERWIEN, A. R., CROSBY, R. D., KUSHNER, M. G., THURAS, P. D., & LAST, C. G. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200003000-00008 · Cited by 216
Essential Psychopharmacology: The Prescriber's Guide
Naussbaum, D. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200602000-00014 · Cited by 213
School Phobia: A Therapeutic Trial with Clomipramine and Short-Term Outcome
Berney, T., Kolvin, I., Bhate, S. R., Garside, R. F., Jeans, J., Kay, B., & Scarth, L. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.138.2.110 · Cited by 198
American Psychiatric Association: Annual Review
&NA;, &. (1986) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198605000-00018 · Cited by 192
Comparative Studies of Pharmacotherapy for School Refusal
BERNSTEIN, G. A., GARFINKEL, B. D., & BORCHARDT, C. M. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199009000-00016 · Cited by 186
Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Five Years
CAMPBELL, M., & SPENCER, E. K. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198805000-00001 · Cited by 182
Another Sudden Death in a Child Treated with Desipramine
RIDDLE, M. A., GELLER, B., & RYAN, N. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199307000-00013 · Cited by 182
Sudden Death in Children Receiving Norpramin®: A Review of Three Reported Cases and Commentary
RIDDLE, M. A., NELSON, J. C., KLEINMAN, C. S., RASMUSSON, A., LECKMAN, J. F., KING, R. A., & COHEN, D. J. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199101000-00016 · Cited by 178
Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents
(1993) · Springer eBooks · doi:10.1007/978-1-4615-2884-5 · Cited by 165
Treatment of School Refusal: One-Year Follow-up
Bernstein, G. A., Hektner, J. M., BORCHARDT, C. M., & MCMILLAN, M. H. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00015 · Cited by 152
Sudden Death in Children Treated with a Tricyclic Antidepressant
Biederman, J. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199105000-00023 · Cited by 148
Geller, B., Cooper, T. B., Graham, D. L., Marsteller, F. A., & Bryant, D. M. (1989) · PubMed · Cited by 142
Geller, B., Cooper, T. B., GRAHAM, D. L., Fetner, H. H., Marsteller, F., & WELLS, J. M. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00007 · Cited by 131
Clinical Effects of Amitriptyline in Adolescent Depression: A Pilot Study
Kramer, A. D., & Feiguine, R. J. (1981) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)61650-2 · Cited by 129
Response to Desipramine Treatment in Adolescent Depression: A Fixed-Dose, Placebo-Controlled Trial
Kutcher, S., Boulos, C., Ward, B., Marton, P., SIMEON, J. G., Ferguson, H. B., Szalai, J. P., KATIC, M., Roberts, N., Dubois, C., et al. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199406000-00010 · Cited by 118
Birmaher, B. B., Waterman, G. S., Ryan, N. D., Perel, J. M., McNabb, J., BALACH, L., Beaudry, M. B., NASR, F. N., KARAMBELKAR, J., ELTERICH, G., et al. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199805000-00015 · Cited by 115
Family Dimensions in Anxious–Depressed School Refusers
Bernstein, G. A., Warren, S. L., Massie, E. D., & THURAS, P. D. (1999) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(99)00021-3 · Cited by 95
Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial
Sallee, F. R., Vrindavanam, N. S., Deas-Nesmith, D., Carson, S. W., & Sethuraman, G. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.668 · Cited by 93
Case Study: Two Additional Sudden Deaths With Tricyclic Antidepressants
Varley, C. K., & McClellan, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199703000-00018 · Cited by 90
Geller, B., FOX, L. W., & FLETCHER, M. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199301000-00007 · Cited by 88
The effect of concomitant disorders in childhood depression on predicting treatment response.
HUGHES, C. W., Preskorn, S. H., Weller, E., Weller, R. A., Hassanein, R., & Tucker, S. (1990) · PubMed · Cited by 87
Kye, C., Waterman, G. S., Ryan, N. D., Birmaher, B. B., Williamson, D. E., Iyengar, S., & DACHILLE, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199609000-00011 · Cited by 87
Depression in children: relationship between plasma imipramine levels and response.
Preskorn, S. H., Eb, W., & Ra, W. (1982) · PubMed · Cited by 82
Amitriptyline in Children with Major Depressive Disorder: A Double-Blind Crossover Pilot Study
Kashani, J. H., Shekim, W. O., & Reid, J. C. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60515-x · Cited by 76
Predictors of treatment response in anxious-depressed adolescents with school refusal
LAYNE, A. E., BERNSTEIN, G. A., EGAN, E. A., & KUSHNER, M. G. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200303000-00012 · Cited by 73
Suicide among Youth: Perspectives on Risk and Prevention
Kashani, J. H. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199011000-00038 · Cited by 72
Comparison of Toxicity of Acute Overdoses with Citalopram and Escitalopram
Hayes, B. D., Klein‐Schwartz, W., Clark, R. F., Muller, A. A., & Miloradovich, J. E. (2008) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2008.06.030 · Cited by 64
Imipramine Treatment of Depressed Children
Petti, T. A., & LAW, W. (1982) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198204000-00004 · Cited by 63
Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents
WERRY, J. S., & Aman, M. G. (1999) · Springer eBooks · doi:10.1007/978-1-4899-0086-9 · Cited by 54
Phillips, S., Brent, J. A., Kulig, K. W., Heiligenstein, J. H., & Birkett, M. A. (1997) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(97)00072-3 · Cited by 51
Psychopharmacology of Child and Adolescent Major Depression: Present Status and Future Directions
Jensen, P. S., Ryan, N. D., & Prien, R. F. (1992) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1992.2.31 · Cited by 50
Adolescent depression: Controlled desipramine treatment and atypical features
KLEIN, R. G., Mannuzza, S., Koplewicz, H. S., TANCER, N. K., Shah, M., Liang, V. X., & Davies, M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1<15::aid-da3>3.0.co;2-4 · Cited by 47
The Pharmacologic Treatment of Child and Adolescent Depression
Ryan, N. D. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30256-9 · Cited by 43
Suicide among youth Perspectives on Risk and Prevention
Pfeffer, C. R. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199107000-00022 · Cited by 41
Response to desipramine treatment in adolescent major depression.
Boulos, C., Kutcher, S., Marton, P., SIMEON, J. G., Ferguson, B., & Roberts, N. (1991) · PubMed · Cited by 41
Imipramine Compliance in Adolescents
Bernstein, G. A., ANDERSON, L. K., Hektner, J. M., & Realmuto, G. M. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200003000-00009 · Cited by 35
Analysis of sertraline-only overdoses
Klein‐Schwartz, W., & Anderson, B. D. (1996) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(96)90150-3 · Cited by 29
AMITRIPTYLINE IN CHILDHOOD DEPRESSIONS.
Lucas, A. R., Hj, L., & Grimm, F. (1965) · PubMed · Cited by 29
Scales of potential use in the psychopharmacologic treatment of depressed children and adolescents.
Ta, P. (1985) · PubMed · Cited by 27
Meta‐analysis of early phase I1 studies with paroxetine in hospitalized depressed patients
Byrne, M. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07194.x · Cited by 20
Selected Tricyclic Antidepressant Ingestions Involving Children 6 Years Old or Less
McFee, R. B., Caraccio, T. R., & Mofenson, H. C. (2001) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2001.tb01278.x · Cited by 18
Are Clinicians Ahead of Researchers in Finding a Treatment for Adolescent Depression?
Popper, C. W. (1992) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1992.2.1 · Cited by 15
Cited by
Mental health of young people: A global public-health challenge
Patel, V., Flisher, A. J., Hetrick, S., & McGorry, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60368-7 · Cited by 3,126
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Exercise in prevention and treatment of anxiety and depression among children and young people
Larun, L., Nordheim, L. V., Ekeland, E., Hagen, K. B., & Heian, F. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004691.pub2 · Cited by 492
Metadata
- Authors
- Hazell, P., & Mirzaie, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-06-18
- Volume
- 2013
- Issue
- 6
- Pages
- CD002317-CD002317
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1736508677
- Cited by
- 286
- References
- 53
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.